Print page content Print
Increase text size Decrease text size
Text Size

Excede Expectations

1 single shot.
2 critical stages of development.
7 full days of protection.

One injection of EXCEDE®188体育平台 for Swine (ceftiofur crystalline free acid) Sterile Suspension treats and controls swine respiratory disease for 7 days. It continuously attacks a broad range of pathogens.* And EXCEDE is proven effective for both weaning and nursery—the 2 critical stages in a young pig’s development. So you can have a healthy pig—and a healthy herd—for the long term.

*A pleuropneumoniae, H parasuis, P multocida, S suis.

Expand All
  • Count on EXCEDE
    188体育平台 Swine respiratory disease (SRD) continues to be an important health concern for producers. EXCEDE offers treatment against the following bacteria associated with SRD:

    • Actinobacillus pleuropneumoniae
    • Pasteurella multocida
    • Haemophilus parasuis
    • Streptococcus suis

    It also controls SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, and Streptococcus suis in groups of pigs where SRD has been diagnosed.

    188体育平台These bacteria are extremely sensitive to ceftiofur, as the chart below shows. The minimum inhibitory concentration (MIC) values for these pathogens are very low.

    MIC values from field trial isolates 

    Pathogen

    Number of Isolates

    MIC90*(µg/mL)

    A. pleuropneumoniae

    28

    ≤ 0.03

    P. multocida

    58

    ≤ 0.03

    S. suis type II

    41

    0.12

    H. parasuis**

    72

    0.06

    *MIC for 90 percent of the isolates.
    ** These MIC data were obtained during NCCLS procedures, but quality control values for
    H. parasuis188体育平台 had not been standardized.

    Seven days of treatment

    EXCEDE is the only single dose injectable antibiotic approved for swine that delivers at least 7 days of therapeutic plasma levels with one injection1. This makes it the right product to use first for treating SRD.

    The figure below shows the plasma profile for a single intramuscular injection (IM) dose of 5.0 mg/kg EXCEDE for Swine compared with three consecutive daily IM doses of 3.0 mg/kg of NAXCEL® (ceftiofur sodium) Sterile Powder.

    Plasma Concentrations of Active Metabolite

    EXCEDE offers the convenience and confidence you need in one dose.

    1. Study 1121R-60-04-215
  • EXCEDE is a prescription product. Administer by intramuscular injection (IM) in the post-auricular region of the neck as a single dosage of 2.27 mg ceftiofur equivalent (CE)/lb (5.0 mg CE/kg) body weight. This is equivalent to 1.0 mL per 44 lbs (20 kg) body weight (BW). No more than 2.0 mL should be injected in a single injection site.

    As with all drugs, EXCEDE® for Swine should not be administered to pigs known to be hypersensitive to cephalosporins or penicillins. Following label use as a single treatment, a 14-day pre-slaughter withdrawal period is required.

    Packaging

    • EXCEDE is available in 100 mL vials.

 

IMPORTANT SAFETY INFORMATION
People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCEDE. Do not use in swine found to be hypersensitive to the product. Pre-slaughter withdrawal time is 14 days following the last dose.

 

 Product and Prescribing Information

CONTACT US

1-888-963-8471

We are Mon–Fri, 8:30am–8:00pm ET188体育平台

188体育平台

zoetis logo United States flag United States

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

188体育平台All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2020 Zoetis Services LLC. All rights reserved.

优发体育国际 电竞竞猜软件 久发国际 雅虎娱乐 添运国际登陆 乐虎体育官网 山水娱乐官网 u乐平台官网 必赢官网 大发体育官网